Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients.
Br J Cancer
; 112(12): 1904-10, 2015 Jun 09.
Article
in En
| MEDLINE
| ID: mdl-26010413
Full text:
1
Database:
MEDLINE
Main subject:
Lymphocytes
/
Melanoma
/
Antibodies, Monoclonal
/
Neutrophils
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2015
Type:
Article